Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
LY-3537021 by Eli Lilly and Co for Type 2 Diabetes: Likelihood of Approval
LY-3537021 is under clinical development by Eli Lilly and Co and currently in Phase I for Type 2 Diabetes. According...